In Silico Study of the Potential of Garlic Allicin Compound as Anti-Angiogenesis in Breast Cancer doi.org/10.26538/tjnpr/v5i11.17
Main Article Content
Abstract
The angiogenesis process in breast cancer has an important role in the development of tumors, metastases, and is also associated with a decrease in breast cancer patients’ survival. Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a major role in the angiogenesis process. VEGFR-2 inhibition is expected to ably inhibit breast cancer cells growth, especially triple-negative breast cancer. Allicin from single garlic has an antioxidant and anticarcinogenic effect similar to N-Acetyl Cysteine (NAC). This study aims to evaluate Allicin compound from single garlic as an angiogenic potential inhibitor of VEGFR-2 breast cancer through an in silico study. The study used ChemDraw Professional 16.0 program, Chem 3D 16.0, and Molegro Virtual Docker-5. VEGFR-2 receptor used in this study was with PDB code: 4ASD, which had a native ligand Sorafenib (BAX_1500). Data analysis were performed by comparing the binding energy of the VEGFR-2 receptor with Allicin and NAC ligands as Rerank Score. Absorption, Distribution, Metabolism, and Excretion (ADME) and toxicity of compounds were tested using pkCSM online tool program. The results of re-docking process showed that the Root MeanSquare Deviation (RMSD) was less than 2 (0.868). The in silico test showed that Allicin had lower anti-angiogenesis potential than NAC (Bond energy: Sorafenib: -155.145 Kcal/mol, Allicin: -54.2265 Kcal/mol, and NAC: -57.5174 Kcal/mol). However, the safety profile test using pkCSM online tool showed that Allicin had a better profile than NAC, both in pharmacokinetics and toxicity. In conclusion, the Allicin compound from single garlic is an angiogenic potential inhibitor of VEGFR-2 breast cancer through an in-silico study.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
The Global Cancer Observatory. Cancer Incident in Indonesia. Vol. 858, International Agency for Research on Cancer. 2020.
Aventurado CA, Billones JB, Vasquez RD, Castillo AL. In ovo and in silico evaluation of the anti-angiogenic potential of syringin. Drug Des Devel Ther. 2020 Nov 25;14:5189–204.
Srinivas M. Cytochrome P450 Enzymes, Drug Transporters and their Role in Pharmacokinetic Drug-Drug Interactions of Xenobiotics: A Comprehensive Review. Open J Chem. 2017 Jul 11;3(1):001–11.
Yan JD, Liu Y, Zhang ZY, Liu GY, Xu JH, Liu LY, Xu JH, Liu LY, Hu YM. Expression and prognostic significance of VEGFR-2 in breast cancer. Pathol Res Pract. 2015 Jul 1;211(7):539–43.
Zhu X, Zhou W. The emerging regulation of VEGFR-2 in triplenegative breast cancer. Front Endocrinol (Lausanne). 2015;6(OCT):159.
Dattachoudhury S, Sharma R, Kumar A, Jaganathan BG. Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells. Oncol. 2020 Jul 1;98(7):478–86.
Tenório MCDS, Graciliano NG, Moura FA, de Oliveira ACM, Goulart MOF. N-acetylcysteine (Nac): Impacts on human health.
Antioxidants. 2021;10(6):967.
Sceneay J, Liu MCP, Chen A, Wong CSF, Bowtell DDL, Möller A. The Antioxidant N-Acetylcysteine Prevents HIF-1 Stabilization under Hypoxia In Vitro but Does Not Affect Tumorigenesis in Multiple Breast Cancer Models In Vivo. PLoS One. 2013 Jun 20;8(6):e66388.
Batiha GES, Beshbishy AM, Wasef LG, Elewa YHA, Al-Sagan AA, El-Hack MEA, Taha AE, Abd-Elhakim YM, Devakota HP. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): A review. Vol. 12, Nutrients. Multidisciplinary Digital Publishing Institute (MDPI); 2020.
Borlinghaus J, Albrecht F, Gruhlke MCH, Nwachukwu ID, Slusarenko AJ. Allicin: Chemistry and biological properties. Molecules. 2014;19(8):12591–618.
Allicin | C6H10OS2 - PubChem. US National library of medicine. 2016. p. 1.
McTigue M, Murray BW, Chen JH, Deng Y-L, Solowiej J, Kania RS. 4ASD - Crystal Structure of VEGFR2 (Juxtamembrane and Kinase Domains) in Complex with SORAFENIB (BAY 43-9006). Protein Data Bank. 2019.
Purnomo H. Computational Chemistry Test In Silico AntiCancer Compound. 1st ed. Yogyakarta: Pustaka Pelajar; 2013.
NCI. Online SMILES Translator. 2011.
Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting smallmolecule pharmacokinetic and toxicity properties using graphbased signatures. J Med Chem. 2015;58(9):4066–72.
Muchtaridi, A. Y, Megantara S, Purnomo H. Medical Chemistry: Fundamentals in Drug Design. 1st ed. Jakarta: Prenadamedia
Group; 2018. 143–192 p.
Neidle S. Design Principles for Quadruplex-binding Small Molecules. In: Therapeutic Applications of Quadruplex Nucleic Acids. Academic Press; 2012. p. 151–74.
Chander S, Tang CR, Al-Maqtari HM, Jamalis J, Penta A, Hadda T Ben, et al. Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives. Bioorg Chem. 2017 Jun 1;72:74–9.
Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting smallmolecule pharmacokinetic and toxicity properties using graphbased signatures. J Med Chem. 2015 May 14;58(9):4066–72.
Pea F. Principles of Pharmacodynamics and Pharmacokinetics of Drugs Used in Extracorporeal Therapies. In: Critical Care Nephrology: Third Edition. Elsevier; 2019. p. 892-896.e1.
Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH. Assessment of substrate-dependent ligand interactions at the
organic cation transporter OCT2 using six model substrates s. Mol Pharmacol. 2018 Sep 1;94(3):1057–68.
Jain AK, Singh D, Dubey K, Maurya R, Mittal S, Pandey AK. Models and Methods for In Vitro Toxicity. In: In Vitro Toxicology. Academic Press; 2018. 45–65 p.
Nikmaturrohana Q, Lestari SR, Lukiati B. Potential of single bulb garlic (Allium sativum) active compound as an 11β-HSD1 inhibitor in obesity through in silico method. In: AIP Conference Proceedings. Malang; 2020. p. 040032.
Chan PK, Hayes AW. Acute Toxicity and Eye Irritancy. In: Hayes’ Principles and Methods of Toxicology. CRC Press; 2014. p. 1143–98.